Alembic Pharma Head of International Business Formulations Prashant Khandelwal resigns
Vadodara: Alembic Pharma has announced that Prashant Khandelwal, Head-International Business Formulations, has resigned from his position. He will be relieved from his role effective December 1, 2025, after closure of business hours.
Khandelwal has over two decades of experience in pharmaceutical marketing & selling of formulations (OSD, injectables, topicals) in various countries in Latin America, CIS (including Russia), ASEAN, Australia & Africa.
He has proven experience in aligning team members across different geographies and departments to deliver high productivity with clearly defined objectives and rewards.
Before joining Alembic, Khandelwal worked at Dr Reddy's Labs in various roles. He also served at Strides Acrolab, and Ranbaxy.
Read also: Alembic Pharma gets USFDA okay for Sumatriptan Injection, Single Dose Autoinjector System
Headquartered in India, Alembic Pharmaceuticals Limited is a vertically integrated research and development pharmaceutical company. It is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA.
Read also: Alembic Pharma bags USFDA nod for erosive esophagitis drug Dexlansoprazole Delayed Release
